ANIFROLUMAB
UNII 38RL9AE51Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Anifrolumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 38RL9AE51Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1326232-46-5 and the RxNorm Concept ID (RxCUI) 2565265. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

38RL9AE51Q

CAS Registry Number

1326232-46-5

RxNorm Concept ID

2565265

Detailed Substance Profile

Preferred Name

ANIFROLUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

38RL9AE51Q

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166658

National Cancer Institute reference terminology for clinical and research data.

INN ID

9800

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-55

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anifrolumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANIFROLUMAB

ANIFROLUMAB-FNIA

Common Names & Synonyms

ANIFROLUMAB [INN]

ANIFROLUMAB [JAN]

ANIFROLUMAB [USAN]

ANIFROLUMAB [WHO-DD]

ANIFROLUMAB FNIA [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON .ALPHA./.BETA. RECEPTOR) (HUMAN MONOCLONAL MEDI-546 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI-546 .KAPPA.-CHAIN, DIMER